Date | Cash and Short-Term Investments | Receivables | Inventory | Goodwill |
---|
CEO | Mr. Pradeep Patni |
IPO Date | Jan. 29, 2007 |
Location | India |
Headquarters | BSEL Tech Park, B-Wing |
Employees | 1,491 |
Sector | Healthcare |
Industries |
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Past 5 years
USD 2.62
USD 9.86
USD 3.47
USD 14.57
StockViz Staff
February 2, 2025
Any question? Send us an email